Christina Kim

Oct 5, 2024 | ipra.org | Christina Kim

Communications is truly global now, and that wide perspective allows (even demands) us to seek inspiration in previously unexpected places. South Korea, for example, is a country that ranks only 29th in the world by population size, but its influence on global culture today is truly immense.

Oct 2, 2024 | marqvision.com | Christina Kim

Counterfeit goods and digital piracy are no longer just a nuisance—they’re a $2 trillion global problem. Every day, brands face increasingly sophisticated threats from counterfeiters that use the latest technology and emerging channels to evade detection. ‍At MarqVision, we’re constantly pushing boundaries in pursuit of a singular mission: to protect and build a future shaped by original ideas, creativity, and innovation.

Feb 8, 2024 | journals.plos.org | Outcomes Science |Jessica IChi Lai |Christina Kim |Amir M. Behdani

Citation: Behdani AM, Lai J, Kim C, Basalelah L, Halsey T, Donohoe KL, et al. (2024) Optimizing pharmacogenomic decision-making by data science. PLOS Digit Health 3(2): e0000451. https://doi.org/10.1371/journal.pdig.0000451Editor: Nino Isakadze, Johns Hopkins Medicine, UNITED STATESReceived: March 27, 2023; Accepted: January 17, 2024; Published: February 8, 2024Copyright: © 2024 Behdani et al.

Jan 4, 2024 | pharmexec.com | Christina Kim

For many growing biotechs, it can be difficult to choose a safety or pharmacovigilance (PV) operating model that works for their organization's size, budget, and case volume. Some biotechs see owning their safety system as their end goal. Others who rely on outside partners for most or all their PV activities may believe that bringing safety in-house isn't an option.

Aug 3, 2023 | tinyurl.com | Dario Bressan |Kai Wang |Christina Kim

(0)eLetters eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter. Log In to Submit a Response